{"id":"https://openalex.org/W3123779528","doi":"https://doi.org/10.1016/j.ejpb.2021.01.011","title":"Photoinduced cross-linking of formulation buffer amino acids to monoclonal antibodies","display_name":"Photoinduced cross-linking of formulation buffer amino acids to monoclonal antibodies","publication_year":2021,"publication_date":"2021-01-25","ids":{"openalex":"https://openalex.org/W3123779528","doi":"https://doi.org/10.1016/j.ejpb.2021.01.011","mag":"3123779528","pmid":"https://pubmed.ncbi.nlm.nih.gov/33508437"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejpb.2021.01.011","doi":"https://doi.org/10.1016/j.ejpb.2021.01.011","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejpb.2021.01.011","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0939641121000199/pdf","source":{"id":"https://openalex.org/S122302516","display_name":"European Journal of Pharmaceutics and Biopharmaceutics","issn_l":"0939-6411","issn":["0939-6411","1873-3441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutics and Biopharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0939641121000199/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030932889","display_name":"Thomas Powell","orcid":"https://orcid.org/0000-0002-8308-6510","observed_orcids":["https://orcid.org/0000-0002-8308-6510"]},"institutions":[{"id":"https://openalex.org/I4210134054","display_name":"UCB Pharma (United Kingdom)","ror":"https://ror.org/03428qp74","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210134054","https://openalex.org/I85722119"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Thomas Powell","raw_affiliation_strings":["Biomolecular Formulation and Characterization Sciences, UCB, Slough SL3WE, UK. Electronic address: thomas.powell@ucb.com","Biomolecular Formulation and Characterization Sciences, UCB, Slough SL3WE, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomolecular Formulation and Characterization Sciences, UCB, Slough SL3WE, UK. Electronic address: thomas.powell@ucb.com","institution_ids":["https://openalex.org/I4210134054"]},{"raw_affiliation_string":"Biomolecular Formulation and Characterization Sciences, UCB, Slough SL3WE, UK","institution_ids":["https://openalex.org/I4210134054"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059536442","display_name":"Michael J. Knight","orcid":"https://orcid.org/0000-0002-8925-7923","observed_orcids":["https://orcid.org/0000-0002-8925-7923"]},"institutions":[{"id":"https://openalex.org/I4210134054","display_name":"UCB Pharma (United Kingdom)","ror":"https://ror.org/03428qp74","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210134054","https://openalex.org/I85722119"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael J. Knight","raw_affiliation_strings":["Biomolecular Formulation and Characterization Sciences, UCB, Slough SL3WE, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomolecular Formulation and Characterization Sciences, UCB, Slough SL3WE, UK","institution_ids":["https://openalex.org/I4210134054"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056121080","display_name":"Amanda J. Wood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134054","display_name":"UCB Pharma (United Kingdom)","ror":"https://ror.org/03428qp74","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210134054","https://openalex.org/I85722119"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Amanda Wood","raw_affiliation_strings":["Biomolecular Formulation and Characterization Sciences, UCB, Slough SL3WE, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomolecular Formulation and Characterization Sciences, UCB, Slough SL3WE, UK","institution_ids":["https://openalex.org/I4210134054"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075520310","display_name":"John O\u2019Hara","orcid":"https://orcid.org/0000-0001-6977-0044","observed_orcids":["https://orcid.org/0000-0001-6977-0044"]},"institutions":[{"id":"https://openalex.org/I4210134054","display_name":"UCB Pharma (United Kingdom)","ror":"https://ror.org/03428qp74","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210134054","https://openalex.org/I85722119"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John O'Hara","raw_affiliation_strings":["Biomolecular Formulation and Characterization Sciences, UCB, Slough SL3WE, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomolecular Formulation and Characterization Sciences, UCB, Slough SL3WE, UK","institution_ids":["https://openalex.org/I4210134054"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089380565","display_name":"William I. Burkitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134054","display_name":"UCB Pharma (United Kingdom)","ror":"https://ror.org/03428qp74","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210134054","https://openalex.org/I85722119"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"William Burkitt","raw_affiliation_strings":["Biomolecular Formulation and Characterization Sciences, UCB, Slough SL3WE, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomolecular Formulation and Characterization Sciences, UCB, Slough SL3WE, UK","institution_ids":["https://openalex.org/I4210134054"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030932889"],"corresponding_institution_ids":["https://openalex.org/I4210134054"],"apc_list":{"value":3950,"currency":"USD","value_usd":3950},"apc_paid":{"value":3950,"currency":"USD","value_usd":3950},"fwci":0.6437,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.60229799,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"160","issue":null,"first_page":"35","last_page":"41"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histidine-side-chain","display_name":"histidine side chain","score":0.6169999837875366},{"id":"https://openalex.org/keywords/amino-acid-adducts","display_name":"amino acid adducts","score":0.7870000004768372},{"id":"https://openalex.org/keywords/light-induced-degradation","display_name":"light-induced degradation","score":0.621999979019165},{"id":"https://openalex.org/keywords/protein-stability","display_name":"protein stability","score":0.6129999756813049},{"id":"https://openalex.org/keywords/photodegradation","display_name":"photodegradation","score":0.5680000185966492},{"id":"https://openalex.org/keywords/product-quality","display_name":"product quality","score":0.49399998784065247}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7646346092224121},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5766297578811646},{"id":"https://openalex.org/C145018004","wikidata":"https://www.wikidata.org/wiki/Q4985944","display_name":"Buffer (optical fiber)","level":2,"score":0.4716450572013855},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4288623631000519},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.423061341047287},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4105919599533081},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3880019187927246},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3092954158782959},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19234150648117065},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.1884848177433014},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16680949926376343},{"id":"https://openalex.org/C76155785","wikidata":"https://www.wikidata.org/wiki/Q418","display_name":"Telecommunications","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":true},{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002021","descriptor_name":"Buffers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003432","descriptor_name":"Cross-Linking Reagents","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":true},{"descriptor_ui":"D003432","descriptor_name":"Cross-Linking Reagents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008027","descriptor_name":"Light","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011786","descriptor_name":"Quality Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053719","descriptor_name":"Tandem Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059748","descriptor_name":"Proteolysis","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejpb.2021.01.011","doi":"https://doi.org/10.1016/j.ejpb.2021.01.011","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejpb.2021.01.011","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0939641121000199/pdf","source":{"id":"https://openalex.org/S122302516","display_name":"European Journal of Pharmaceutics and Biopharmaceutics","issn_l":"0939-6411","issn":["0939-6411","1873-3441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutics and Biopharmaceutics","raw_type":"journal-article"},{"id":"pmid:33508437","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33508437","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.ejpb.2021.01.011","doi":"https://doi.org/10.1016/j.ejpb.2021.01.011","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejpb.2021.01.011","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0939641121000199/pdf","source":{"id":"https://openalex.org/S122302516","display_name":"European Journal of Pharmaceutics and Biopharmaceutics","issn_l":"0939-6411","issn":["0939-6411","1873-3441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutics and Biopharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3123779528.pdf","grobid_xml":"https://content.openalex.org/works/W3123779528.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1965637212","https://openalex.org/W1967215148","https://openalex.org/W1970041201","https://openalex.org/W1972913960","https://openalex.org/W1977081213","https://openalex.org/W1980042433","https://openalex.org/W1981548035","https://openalex.org/W1987695922","https://openalex.org/W1989943432","https://openalex.org/W2001275409","https://openalex.org/W2007100595","https://openalex.org/W2019898105","https://openalex.org/W2021455647","https://openalex.org/W2035218123","https://openalex.org/W2038373191","https://openalex.org/W2041173360","https://openalex.org/W2048814278","https://openalex.org/W2061932771","https://openalex.org/W2073948759","https://openalex.org/W2086604471","https://openalex.org/W2115012404","https://openalex.org/W2120581064","https://openalex.org/W2146963696","https://openalex.org/W2151533302","https://openalex.org/W2332170505","https://openalex.org/W2415919786","https://openalex.org/W2513745190","https://openalex.org/W2517025561","https://openalex.org/W2565843771","https://openalex.org/W2575449201","https://openalex.org/W2618030325","https://openalex.org/W2709833432","https://openalex.org/W2743913036","https://openalex.org/W2746389381","https://openalex.org/W2751949649","https://openalex.org/W2789674105","https://openalex.org/W2802582474","https://openalex.org/W2807231165","https://openalex.org/W2904971004","https://openalex.org/W2948798149","https://openalex.org/W2966457112","https://openalex.org/W2967208725","https://openalex.org/W2976365784","https://openalex.org/W3014709736","https://openalex.org/W3023240241"],"related_works":["https://openalex.org/W3023240241","https://openalex.org/W1980042433","https://openalex.org/W3182636014","https://openalex.org/W4384945488","https://openalex.org/W3135212758","https://openalex.org/W4402555545","https://openalex.org/W3197863299","https://openalex.org/W2794073903","https://openalex.org/W2007100595","https://openalex.org/W2288593963"],"abstract_inverted_index":{"The":[0,83],"correct":[1],"choice":[2],"of":[3,10,21,52,80,85,115,133,152],"formulation":[4,35,67,119,134],"buffer":[5,135],"is":[6,14],"a":[7,22,140],"critical":[8],"aspect":[9],"drug":[11],"development":[12],"and":[13,25,43,60,121],"chosen":[15],"primarily":[16],"to":[17,74,98],"improve":[18],"the":[19,49,72,76,81,113,131],"stability":[20],"protein":[23],"therapeutic":[24],"protect":[26,148],"against":[27,149],"degradation.":[28],"Amino":[29],"acids":[30,63,117,137],"are":[31],"frequently":[32],"incorporated":[33],"into":[34],"buffers.":[36,68],"In":[37],"this":[38],"study":[39],"we":[40,110],"have":[41,71,139],"identified":[42,88],"characterized":[44],"light":[45],"induced":[46],"cross-links":[47],"between":[48],"side":[50],"chain":[51],"histidine":[53],"residues":[54],"in":[55,66,118],"an":[56],"IgG4":[57],"monoclonal":[58],"antibody":[59],"different":[61],"amino":[62,116,136],"commonly":[64],"used":[65],"These":[69],"reactions":[70],"potential":[73],"impact":[75,142],"overall":[77],"product":[78,144],"quality":[79],"drug.":[82],"structure":[84],"each":[86],"cross-link":[87],"was":[89],"elucidated":[90],"using":[91],"high":[92],"performance":[93],"liquid":[94],"chromatography":[95],"(HPLC)":[96],"hyphenated":[97],"tandem":[99],"mass":[100],"spectrometry":[101],"(MS/MS)":[102],"with":[103],"higher":[104],"energy":[105],"collisional":[106],"dissociation":[107],"(HCD).":[108],"Furthermore,":[109],"speculate":[111],"on":[112,124,143],"role":[114],"buffers":[120],"their":[122],"influence":[123],"mAb":[125],"stability.":[126],"We":[127],"theorize":[128],"that":[129],"whilst":[130],"adduction":[132],"could":[138],"negative":[141],"quality,":[145],"it":[146],"may":[147],"other":[150],"pathways":[151],"photo-degradation.":[153]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-02-01T00:00:00"}